Document is current
Any future updates will be listed below
-
Authors
Fouladi, Farnaz https://orcid.org/0000-0003-4369-8720
Brooks, Amanda E.
Fodor, Anthony A.
Carroll, Ian M.
Bulik-Sullivan, Emily C.
Tsilimigras, Matthew C. B.
Sioda, Michael
Steffen, Kristine J.
-
Funding
Funding for this research was provided by:
National Institutes of Health (P30GM103332)
Neuropsychiatric Research Institute (na)
- License Information
-
More Information
Article History
First Online: 2 January 2019
Compliance with Ethical Standards
:
: Ian M. Carroll reports personal fees from Vivelix and Salix pharmaceuticals for being consultant outside the submitted work. Kristine J. Steffen reports grants from the Center for Protease Research - NIH COBRE Pilot Grant through NDSU during the conduct of the study; grants from NIH, grants from Sanford Profile/NDSU, grants from Shire Pharmaceuticals, outside the submitted work. Amanda E. Brooks reports grants from NIH IDEA Center, during the conduct of the study. Anthony A. Fodor reports grants from NIH during the conduct of the study; personal fees from Second Genome, Salix Corporation, and the NKarta corporation outside the submitted work. Farnaz Fouladi, Emily C. Bulik-Sullivan, Matthew C. B. Tsilimigras, and Michael Sioda have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the University of North Dakota and North Dakota State University (NDSU) Institutional Review Boards. The study was registered at (NCT02654496). All Institutional Animal Care and Use Committee of North Dakota State University guidelines for the care and use of animals were followed.
: Informed consent was obtained from all individual participants included in the study<i>.</i>
